Antibodies - Storing and Handling Antibodies for Research
Can't see this email? View it online
   
  August 28, 2019  
  Antibodies  
  The latest antibodies news from News Medical  
 

#ALT# Using a Bridging Assay for Anti-Drug Antibody Detection

Therapeutic drugs that are based on biological materials, like fusion proteins, enzymes, cytokines, hormones, and antibodies, may have the potential to trigger an immune response in the host. Immunogenicity of a therapeutic can be described as the undesirable stimulation of an immune response by the host to the therapeutic.

Find Out More
 
   Storing and Handling Antibodies for ResearchStoring and Handling Antibodies for Research
 
Antibodies are proteins produced by the immune system as part of the body's defense against pathogens. Each antibody is specific to one molecule or a small number of molecules, known as antigens. Antibodies are commonly used in research to understand disease processes. However, care must be taken when handling and storing these proteins.
 
   Improving the Safety of Biotherapeutics: Tracing the Protease Inhibitor AEBSF with RPLC-UVImproving the Safety of Biotherapeutics: Tracing the Protease Inhibitor AEBSF with RPLC-UV
 
This article describes how RPLC-UV can be used to remove the common protease inhibitor, AEBSF, from antibody preparations for therapeutic applications.
 
 Antibody Applications
 
Antibody ApplicationsAntibodies are proteins that can bind to specific molecules called antigens. They have different portions in their Y-shaped structure that can bind to antigens and effector molecules. Several types of antibodies such as primary and secondary and monoclonal and polyclonal antibodies with varying specificities have been developed in recent years.
 
 
 Current and Future Applications of Rabbit Monoclonal Antibodies
 
Current and Future Applications of Rabbit Monoclonal AntibodiesIn most clinical applications, the monoclonal antibodies (mAbs) used are usually of murine origin; however, the small spleen of the mouse is limited in its ability to generate antibodies.
 
 
 HIV Suppression Using Adenovirus-Mediated Gene Therapy
 
HIV Suppression Using Adenovirus-Mediated Gene TherapyResearch on therapies against the Human Immunodeficiency Virus (HIV) has repeatedly demonstrated the potential of broadly neutralizing antibodies (bn-Abs) as successful therapeutic agents. Injection of such antibodies leads to a decrease in viral concentrations in blood. However, repeated injections are necessary to prevent the recovery of the virus.
 
 
 Antibody may help the immune system fight sepsis-related fungal infections
 
Antibody may help the immune system fight sepsis-related fungal infectionsAn antibody that blocks the "programmed cell death" pathway may help the immune system fight off sepsis-related fungal infections, according to animal studies reported in SHOCK: Injury, Inflammation, and Sepsis: Laboratory and Clinical Approaches, Official Journal of the Shock Society.